Job Openings
R&D Leader, Organic Synthesis in a Pharmaceutical Company (Open to ALL Nationalities)
About the job R&D Leader, Organic Synthesis in a Pharmaceutical Company (Open to ALL Nationalities)
Position open to ALL Nationalities
Qualifications required:
1. Have at least 10 years' experience in R&D team management
2. Job Level: Senior
3. PhD in Organic Chemistry
4. Preference will be given to personnel with related working background in chemical generic drugs.
About the Prospective Employer:
Name of Prospective Employer: Zhejiang Starry Pharmaceutical Co. LTD
Zhejiang Starry Pharmaceutical Co. LTD was established in 1997, and is engaged in the research and development, production, sales of x-ct non-ionic iodine-contrast agent series and quinolones series API and intermediate national high-tech enterprises. In March 2016, Starry Pharmaceuticals successfully entered China's a-share market on the Shanghai stock exchange (stock code 603520). The company is currently the largest manufacturer of non-ionic contrast agent API with the largest production capacity in China. It is also one of the companies with the most abundant product lines of X-ray CT contrast agent API in China. The company has stable product quality and has been certified by many developed countries. The company has Zhejiang pharmaceutical research institute, Zhejiang enterprise technology center, Zhejiang non-ionic contrast agent high-tech research center and Zhejiang postdoctoral workstation for R & D and other technical platforms. The R & D center has more than 100 million yuan of instruments and equipment, including 20 synthesis laboratories, 6 analysis laboratories, and 3 100,000-level pilot test amplification workshops, with a total R & D area of more than 5,000 square meters
Development of Iodinated Contrast Agents technology and research on innovative generic drugs
(Position open to ALL Nationalities)
Technical Background
1. Products of interest to us (i.e.with industrialization capacity) are Iohexanol API, iohopanol API, iofortanol API, ioproramine API, iohexanol API and so on. The company's leading product, iohexanol, obtained European Union CEP certificate and Japanese landing certificate. The production capacity and output of iohexanol API of our company are the first in China. Among them, ioppanol obtained EU CEP certificate and Japanese landing certificate; the company's sales volume of ioxanol in 2019 ranked the first in China.
Issues to be solved by the sucessful candidate：
1. Lead the group's drug research and development work, study the future product layout, formulate five-year development plan;
2. Lead the development of new products, lead the research group to carry out special projects;
3. Responsible for the group's overseas business expansion, the opening up of resource channels, and the increase of international influence;
Further goals to be attained by successful candidate：
1. Break-through the bottleneck of generic drug technology, reduce the production cost by more than 10% and increase the yield by 5-10%;
2. Launch 1 or 2 generic drugs with high added value and complete FDA system certification;
3. Increase the market share of the company's contrast agent products in European and American countries by 20%;